SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-045451
Filing Date
2010-09-08
Accepted
2010-09-08 16:34:04
Documents
1
Period of Report
2010-09-03

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c05757_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c05757_4x0.xml 4 9650
  Complete submission text file 0001209191-10-045451.txt   11795
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT ST, SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address
Maimon Yossi (Reporting) CIK: 0001385115 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 101062600